Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request

HASH(0x55d84454b470) ; HASH(0x55d8446872e8)

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
Read More Add to Saved list
  • Additional Information
    • Publication Date:
      2022
    • Collection:
      Ludwig Boltzmann Institute of Health Technology Assessment (LBI-HTA): Repository
    • File Description:
      application/pdf
    • Relation:
      https://eprints.aihta.at/1381/1/Oncology%20Fact%20Sheet%20Nr.96_Update.pdf; Rothschedl, E. and Wolf, S. (2022): Atezolizumab (Tecentriq®) as adjuvant treatment following complete resection and platinum-based chemotherapy for patients with non-small cell lung cancer (NSCLC). Update September 2022. Oncology Fact Sheet Nr. 96.
    • Online Access:
      https://eprints.aihta.at/1381/
      https://eprints.aihta.at/1381/1/Oncology%20Fact%20Sheet%20Nr.96_Update.pdf
    • Rights:
      cc_by
    • Accession Number:
      edsbas.C20B8902